Stocks soared on Monday in the US, catapulting Wall Street back to record heights on a burst of hope that the economy can get back to normal following encouraging data about a potential coronavirus vaccine.
The S&P 500 was 2.7 per cent higher in afternoon trading after Pfizer said an early peek at its vaccine data suggests the shots may be 90 per cent effective at preventing COVID-19, though that doesn’t mean its release is imminent. The index at the heart of many 401(k) accounts is on track to close at an all-time high for the first time in more than two months. The Dow Jones is 4.4 per cent higher while the tech-heavy Nasdaq is flat.
The ASX is poised to follow suit, with futures at 6.32am AEDT pointing to a jump of 157 points or 2.5 per cent at the open.
Global markets also got a boost from a resolution to the long, market-bruising battle for the White House. Democrat Joe Biden over the weekend clinched the last of the electoral votes needed to become the next president.
Treasury yields and oil prices burst higher as the vaccine news allows investors to feel confident about a stronger economic recovery on the way. The yield on the 10-year Treasury shot up from 0.81 per cent before the announcement to 0.95 per cent, a very big move for the bond market and one that shows stronger confidence in the economy. The key rate touched its highest level since March earlier in the morning, according to Tradeweb. US oil jumped 8.3 per cent.
Stocks of companies that most need the economy and the world to return to normal for their profits to heal led the way. An 11.9 per cent surge for Chevron and 12 per cent jump for The Walt Disney Co. amid hopes that people will start driving and flying to theme parks again.
Cruise operators and owners of office buildings and shopping centers were among the market’s biggest winners on expectations people will feel comfortable again riding elevators to a desk or shopping in enclosed stores.
Carnival surged 34.1 per cent, though it’s still down by more than half for 2020 so far. It led a resurgence for what are called “value stocks,” ones whose prices look cheap and had gotten left behind by the rest of the market through the pandemic.
“People are buying those because they see a light at the end of the tunnel,” said Todd Morgan, chairman at Bel Air Investment Advisors.
The Big Tech companies that earlier drove the market higher in the pandemic, in large part because they didn’t need a “normal” economy to succeed, were lagging behind. That kept a lid on the gains for the Nasdaq composite, which rose by less than 0.1 per cent.
Companies whose fortunes soared directly because the pandemic kept everyone hunkered at home, meanwhile, fell sharply. Zoom Video Communications, whose online meetings allow millions of remote students and workers to communicate, sank 14.9 per cent. Grubhub, which benefited from people ordering in for dinner, dropped 10.2 per cent. Etsy, whose online marketplace rode a wave of popularity for handmade masks, lost 12.6 per cent.
If a vaccine for COVID-19 does indeed pan out, analysts say it’s a “game changer” and just what the market had been waiting for. It underscores again how the coronavirus and its effect on the economy are the dominant concerns for investors, much more than who wins what in Washington.
The 90 per cent effectiveness rate for Pfizer’s potential vaccine is what struck Ajay Rajadhyaksha, head of macro research at Barclays.
“If that proves to be correct, it is a significant positive surprise and increases the odds of a quicker return to normalcy,” he said.
Building on last week’s gains, the S&P 500 is up more than 10 per cent in November. Still, analysts caution that several risks remain that could trip up the market’s big recent gains.
Coronavirus counts continue to rise at troubling rates across much of Europe and the United States, so much that several European governments have brought back restrictions on businesses. In the U.S., confirmed coronavirus cases topped 10 million on Monday, the highest in the world.
In Washington, markets are banking on control of Congress remaining split between Democrats and Republicans, which can keep low tax rates and other pro-business policies the status quo in Washington, but that hinges on the result of run-off elections in Georgia in January.
Potential gridlock also makes any potential rescue package for the economy from Congress likely to be smaller than if Democrats had swept control of all of Washington. President Donald Trump, meanwhile, has refused to concede the election.
For now, though, euphoria about a possible return to normal is the dominant force across markets, particularly as it layers on top of the tremendous aid the Federal Reserve has already put in place for the economy.
“Keep in mind that when you remove the virus from the equation, we are set up tremendously well for growth given the unprecedented easy money policies of the Fed,” said Chris Larkin, managing director of trading and investing product at E-Trade Financial.
Pfizer jumped 8.7 per cent as its announcement indicates the company and its German partner, BioNTech, are on track to file an emergency use application for their COVID-19 vaccine with U.S. regulators later this month.
Some investors weren’t able to participate immediately, though. Customers were complaining about problems across several brokerages in the morning. By midday Monday, brokerages said they had resolved some technical issues.
In markets around the world, stocks strengthened amid expectations that a Biden-led White House could tamp down trade tensions that had built under Trump’s administration. Stock markets across Europe jumped more than 4 per cent. In Asia, many markets rose more than 1 per cent
Source: Thanks smh.com